Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 77.09 | 57.04 | 45.57 | 21.74 |
Depreciation/ Depletion | 13.44 | 12.36 | 12.15 | 12.97 |
Non- Cash Items | -6.38 | -4.47 | -1.89 | 22.86 |
Changesin Working Capital | 24.81 | -3.97 | -46.69 | -40.29 |
Cashfrom Operating Activities | 108.96 | 60.97 | 9.13 | 17.27 |
Capital Expenditures | -37.68 | -70.89 | -14.80 | -5.85 |
Other Investing Cash Flow Items Total | -54.38 | 56.78 | -139.77 | -14.35 |
Cashfrom Investing Activities | -92.07 | -14.11 | -154.58 | -20.20 |
Financing Cash Flow Items | -1.11 | -1.92 | -9.20 | -2.64 |
Total Cash Dividends Paid | -8.30 | -7.63 | - | - |
Issuance( Retirement)of Stock Net | -4.02 | -27.19 | 165.00 | - |
Issuance( Retirement)of Debt Net | -1.86 | -6.99 | -25.71 | 3.42 |
Cashfrom Financing Activities | -15.29 | -43.74 | 130.09 | 0.78 |
Net Changein Cash | 1.60 | 3.12 | -15.36 | -2.15 |
Cash Interest Paid | 1.11 | 0.79 | 1.42 | 1.37 |
Cash Taxes Paid | 18.65 | 9.72 | 8.88 | 6.53 |
Windlas Biotech Dividend Windlas Biotech Bonus Windlas Biotech News Windlas Biotech AGM Windlas Biotech Rights Windlas Biotech Splits Windlas Biotech Board Meetings Windlas Biotech Key Metrics Windlas Biotech Shareholdings Windlas Biotech Profit Loss Windlas Biotech Balance Sheet Windlas Biotech Q1 Results Windlas Biotech Q2 Results Windlas Biotech Q3 Results Windlas Biotech Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks